Industry Research Reports
Home > Reports > Pharma & Healthcare > Global Colloids (Blood Plasma) Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Colloids (Blood Plasma) Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Pharma & Healthcare
Published Date: 2025-09-11
Pages: 189 Pages
Report ld: 5042282
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Colloids (Blood Plasma) Market Size(US$)
CAGR 2025-2031
-2.49%
Market Size,2031
USD 325
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 378 million
Market Forecast in 2031(Value)
US$ 325 million
CAGR
-2.49%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Colloids (Blood Plasma) market is projected to grow from US$ 387 million in 2024 to US$ 325 million by 2031, at a CAGR of -2.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.
North America is the largest Colloids (Blood Plasma) market with about 33% market share. Europe is follower, accounting for about 28% market share.
The key players are CSL Behring, Baxter, Grifols, Octapharma, Kedrion, Shanghai Raas, CTBB, Hualan Bio, Rongsheng Pharmaceutical, Boya Rongsheng, B. Braun Medical, Fresenius Kabi, HOSPIRA, Axa parenterals, Fresenius Kabi(China), CR Double-Crane, Kelun Group, Shandong Qidu Pharmaceutical, Shandong Hualu Pharmaceutical, Minsheng Pharma, Kanglepharm etc. Top 3 companies occupied about 46% market share.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Colloids (Blood Plasma) market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- CSL Behring
- Baxter
- Grifols
- Octapharma
- Kedrion
- Shanghai Raas
- CTBB
- Hualan Bio
- Rongsheng Pharmaceutical
- Boya Rongsheng
- B. Braun Medical
- Fresenius Kabi
- HOSPIRA
- Axa parenterals
- Fresenius Kabi (China)
- CR Double-Crane
- Kelun Group
- Shandong Qidu Pharmaceutical
- Shandong Hualu Pharmaceutical
- Minsheng Pharma
- Kanglepharm
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Natural Type Colloids (Blood Plasma)
- Synthetic Type Colloids (Blood Plasma)
Segment by Application
- Extensive Burns
- Massive Blood or Plasma Loss
- Hypovolemic Shock
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Colloids (Blood Plasma) study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Colloids (Blood Plasma): Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Colloids (Blood Plasma) Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Natural Type Colloids (Blood Plasma)
1.2.3 Synthetic Type Colloids (Blood Plasma)
1.3 Market Segmentation by Application
1.3.1 Global Colloids (Blood Plasma) Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Extensive Burns
1.3.3 Massive Blood or Plasma Loss
1.3.4 Hypovolemic Shock
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Colloids (Blood Plasma) Revenue Estimates and Forecasts 2020-2031
2.2 Global Colloids (Blood Plasma) Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Colloids (Blood Plasma) Sales Estimates and Forecasts 2020-2031
2.4 Global Colloids (Blood Plasma) Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Colloids (Blood Plasma) Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Colloids (Blood Plasma) Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Natural Type Colloids (Blood Plasma) Market Size by Manufacturers
3.5.2 Synthetic Type Colloids (Blood Plasma) Market Size by Manufacturers
3.6 Global Colloids (Blood Plasma) Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Colloids (Blood Plasma) Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Colloids (Blood Plasma) Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Colloids (Blood Plasma) Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Colloids (Blood Plasma) Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Colloids (Blood Plasma) Sales and Revenue by Type (2020-2031)
6.4 North America Colloids (Blood Plasma) Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Colloids (Blood Plasma) Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Colloids (Blood Plasma) Sales and Revenue by Type (2020-2031)
7.4 Europe Colloids (Blood Plasma) Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Colloids (Blood Plasma) Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Colloids (Blood Plasma) Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Colloids (Blood Plasma) Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Colloids (Blood Plasma) Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Colloids (Blood Plasma) Sales and Revenue by Type (2020-2031)
9.4 Central and South America Colloids (Blood Plasma) Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Colloids (Blood Plasma) Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Colloids (Blood Plasma) Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Colloids (Blood Plasma) Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Colloids (Blood Plasma) Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 CSL Behring
11.1.1 CSL Behring Corporation Information
11.1.2 CSL Behring Business Overview
11.1.3 CSL Behring Colloids (Blood Plasma) Product Models, Descriptions and Specifications
11.1.4 CSL Behring Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 CSL Behring Colloids (Blood Plasma) Sales by Product in 2024
11.1.6 CSL Behring Colloids (Blood Plasma) Sales by Application in 2024
11.1.7 CSL Behring Colloids (Blood Plasma) Sales by Geographic Area in 2024
11.1.8 CSL Behring Colloids (Blood Plasma) SWOT Analysis
11.1.9 CSL Behring Recent Developments
11.2 Baxter
11.2.1 Baxter Corporation Information
11.2.2 Baxter Business Overview
11.2.3 Baxter Colloids (Blood Plasma) Product Models, Descriptions and Specifications
11.2.4 Baxter Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Baxter Colloids (Blood Plasma) Sales by Product in 2024
11.2.6 Baxter Colloids (Blood Plasma) Sales by Application in 2024
11.2.7 Baxter Colloids (Blood Plasma) Sales by Geographic Area in 2024
11.2.8 Baxter Colloids (Blood Plasma) SWOT Analysis
11.2.9 Baxter Recent Developments
11.3 Grifols
11.3.1 Grifols Corporation Information
11.3.2 Grifols Business Overview
11.3.3 Grifols Colloids (Blood Plasma) Product Models, Descriptions and Specifications
11.3.4 Grifols Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Grifols Colloids (Blood Plasma) Sales by Product in 2024
11.3.6 Grifols Colloids (Blood Plasma) Sales by Application in 2024
11.3.7 Grifols Colloids (Blood Plasma) Sales by Geographic Area in 2024
11.3.8 Grifols Colloids (Blood Plasma) SWOT Analysis
11.3.9 Grifols Recent Developments
11.4 Octapharma
11.4.1 Octapharma Corporation Information
11.4.2 Octapharma Business Overview
11.4.3 Octapharma Colloids (Blood Plasma) Product Models, Descriptions and Specifications
11.4.4 Octapharma Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Octapharma Colloids (Blood Plasma) Sales by Product in 2024
11.4.6 Octapharma Colloids (Blood Plasma) Sales by Application in 2024
11.4.7 Octapharma Colloids (Blood Plasma) Sales by Geographic Area in 2024
11.4.8 Octapharma Colloids (Blood Plasma) SWOT Analysis
11.4.9 Octapharma Recent Developments
11.5 Kedrion
11.5.1 Kedrion Corporation Information
11.5.2 Kedrion Business Overview
11.5.3 Kedrion Colloids (Blood Plasma) Product Models, Descriptions and Specifications
11.5.4 Kedrion Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Kedrion Colloids (Blood Plasma) Sales by Product in 2024
11.5.6 Kedrion Colloids (Blood Plasma) Sales by Application in 2024
11.5.7 Kedrion Colloids (Blood Plasma) Sales by Geographic Area in 2024
11.5.8 Kedrion Colloids (Blood Plasma) SWOT Analysis
11.5.9 Kedrion Recent Developments
11.6 Shanghai Raas
11.6.1 Shanghai Raas Corporation Information
11.6.2 Shanghai Raas Business Overview
11.6.3 Shanghai Raas Colloids (Blood Plasma) Product Models, Descriptions and Specifications
11.6.4 Shanghai Raas Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Shanghai Raas Recent Developments
11.7 CTBB
11.7.1 CTBB Corporation Information
11.7.2 CTBB Business Overview
11.7.3 CTBB Colloids (Blood Plasma) Product Models, Descriptions and Specifications
11.7.4 CTBB Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 CTBB Recent Developments
11.8 Hualan Bio
11.8.1 Hualan Bio Corporation Information
11.8.2 Hualan Bio Business Overview
11.8.3 Hualan Bio Colloids (Blood Plasma) Product Models, Descriptions and Specifications
11.8.4 Hualan Bio Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Hualan Bio Recent Developments
11.9 Rongsheng Pharmaceutical
11.9.1 Rongsheng Pharmaceutical Corporation Information
11.9.2 Rongsheng Pharmaceutical Business Overview
11.9.3 Rongsheng Pharmaceutical Colloids (Blood Plasma) Product Models, Descriptions and Specifications
11.9.4 Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Rongsheng Pharmaceutical Recent Developments
11.10 Boya Rongsheng
11.10.1 Boya Rongsheng Corporation Information
11.10.2 Boya Rongsheng Business Overview
11.10.3 Boya Rongsheng Colloids (Blood Plasma) Product Models, Descriptions and Specifications
11.10.4 Boya Rongsheng Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Boya Rongsheng Recent Developments
11.11 B. Braun Medical
11.11.1 B. Braun Medical Corporation Information
11.11.2 B. Braun Medical Business Overview
11.11.3 B. Braun Medical Colloids (Blood Plasma) Product Models, Descriptions and Specifications
11.11.4 B. Braun Medical Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 B. Braun Medical Recent Developments
11.12 Fresenius Kabi
11.12.1 Fresenius Kabi Corporation Information
11.12.2 Fresenius Kabi Business Overview
11.12.3 Fresenius Kabi Colloids (Blood Plasma) Product Models, Descriptions and Specifications
11.12.4 Fresenius Kabi Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Fresenius Kabi Recent Developments
11.13 HOSPIRA
11.13.1 HOSPIRA Corporation Information
11.13.2 HOSPIRA Business Overview
11.13.3 HOSPIRA Colloids (Blood Plasma) Product Models, Descriptions and Specifications
11.13.4 HOSPIRA Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 HOSPIRA Recent Developments
11.14 Axa parenterals
11.14.1 Axa parenterals Corporation Information
11.14.2 Axa parenterals Business Overview
11.14.3 Axa parenterals Colloids (Blood Plasma) Product Models, Descriptions and Specifications
11.14.4 Axa parenterals Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Axa parenterals Recent Developments
11.15 Fresenius Kabi (China)
11.15.1 Fresenius Kabi (China) Corporation Information
11.15.2 Fresenius Kabi (China) Business Overview
11.15.3 Fresenius Kabi (China) Colloids (Blood Plasma) Product Models, Descriptions and Specifications
11.15.4 Fresenius Kabi (China) Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Fresenius Kabi (China) Recent Developments
11.16 CR Double-Crane
11.16.1 CR Double-Crane Corporation Information
11.16.2 CR Double-Crane Business Overview
11.16.3 CR Double-Crane Colloids (Blood Plasma) Product Models, Descriptions and Specifications
11.16.4 CR Double-Crane Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 CR Double-Crane Recent Developments
11.17 Kelun Group
11.17.1 Kelun Group Corporation Information
11.17.2 Kelun Group Business Overview
11.17.3 Kelun Group Colloids (Blood Plasma) Product Models, Descriptions and Specifications
11.17.4 Kelun Group Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Kelun Group Recent Developments
11.18 Shandong Qidu Pharmaceutical
11.18.1 Shandong Qidu Pharmaceutical Corporation Information
11.18.2 Shandong Qidu Pharmaceutical Business Overview
11.18.3 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product Models, Descriptions and Specifications
11.18.4 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 Shandong Qidu Pharmaceutical Recent Developments
11.19 Shandong Hualu Pharmaceutical
11.19.1 Shandong Hualu Pharmaceutical Corporation Information
11.19.2 Shandong Hualu Pharmaceutical Business Overview
11.19.3 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product Models, Descriptions and Specifications
11.19.4 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 Shandong Hualu Pharmaceutical Recent Developments
11.20 Minsheng Pharma
11.20.1 Minsheng Pharma Corporation Information
11.20.2 Minsheng Pharma Business Overview
11.20.3 Minsheng Pharma Colloids (Blood Plasma) Product Models, Descriptions and Specifications
11.20.4 Minsheng Pharma Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2020-2025)
11.20.5 Minsheng Pharma Recent Developments
11.21 Kanglepharm
11.21.1 Kanglepharm Corporation Information
11.21.2 Kanglepharm Business Overview
11.21.3 Kanglepharm Colloids (Blood Plasma) Product Models, Descriptions and Specifications
11.21.4 Kanglepharm Colloids (Blood Plasma) Sales, Price, Revenue and Gross Margin (2020-2025)
11.21.5 Kanglepharm Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Colloids (Blood Plasma) Industry Chain
12.2 Colloids (Blood Plasma) Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Colloids (Blood Plasma) Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Colloids (Blood Plasma) Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Colloids (Blood Plasma) Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Colloids (Blood Plasma) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Colloids (Blood Plasma) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Colloids (Blood Plasma) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Colloids (Blood Plasma) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Colloids (Blood Plasma) Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Colloids (Blood Plasma) Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Colloids (Blood Plasma) Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (MT)
Table 7. Global Colloids (Blood Plasma) Sales by Region (2020-2025) & (MT)
Table 8. Global Colloids (Blood Plasma) Sales by Region (2026-2031) & (MT)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Colloids (Blood Plasma) Sales by Manufacturers (2020-2025) & (MT)
Table 11. Global Colloids (Blood Plasma) Sales Share by Manufacturers (2020-2025)
Table 12. Global Colloids (Blood Plasma) Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Colloids (Blood Plasma) Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Colloids (Blood Plasma) by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colloids (Blood Plasma) as of 2024)
Table 16. Global Colloids (Blood Plasma) Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Colloids (Blood Plasma) Average Selling Price (ASP) by Manufacturers (2020-2025) & (USD/Kg)
Table 18. Key Manufacturers Colloids (Blood Plasma) Manufacturing Base and Headquarters
Table 19. Global Colloids (Blood Plasma) Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Colloids (Blood Plasma) Sales by Type (2020-2025) & (MT)
Table 23. Global Colloids (Blood Plasma) Sales by Type (2026-2031) & (MT)
Table 24. Global Colloids (Blood Plasma) Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Colloids (Blood Plasma) Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Colloids (Blood Plasma) ASP by Type (2020-2031) & (USD/Kg)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Colloids (Blood Plasma) Sales by Application (2020-2025) & (MT)
Table 29. Global Colloids (Blood Plasma) Sales by Application (2026-2031) & (MT)
Table 30. Colloids (Blood Plasma) High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Colloids (Blood Plasma) Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Colloids (Blood Plasma) Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Colloids (Blood Plasma) ASP by Application (2020-2031) & (USD/Kg)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Colloids (Blood Plasma) Growth Accelerators and Market Barriers
Table 37. North America Colloids (Blood Plasma) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Colloids (Blood Plasma) Sales (MT) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Colloids (Blood Plasma) Growth Accelerators and Market Barriers
Table 40. Europe Colloids (Blood Plasma) Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Colloids (Blood Plasma) Sales (MT) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Colloids (Blood Plasma) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Colloids (Blood Plasma) Sales (MT) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Colloids (Blood Plasma) Growth Accelerators and Market Barriers
Table 45. Southeast Asia Colloids (Blood Plasma) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Colloids (Blood Plasma) Investment Opportunities and Key Challenges
Table 47. Central and South America Colloids (Blood Plasma) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Colloids (Blood Plasma) Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Colloids (Blood Plasma) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. CSL Behring Corporation Information
Table 51. CSL Behring Description and Major Businesses
Table 52. CSL Behring Product Models, Descriptions and Specifications
Table 53. CSL Behring Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 54. CSL Behring Sales Value Proportion by Product in 2024
Table 55. CSL Behring Sales Value Proportion by Application in 2024
Table 56. CSL Behring Sales Value Proportion by Geographic Area in 2024
Table 57. CSL Behring Colloids (Blood Plasma) SWOT Analysis
Table 58. CSL Behring Recent Developments
Table 59. Baxter Corporation Information
Table 60. Baxter Description and Major Businesses
Table 61. Baxter Product Models, Descriptions and Specifications
Table 62. Baxter Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 63. Baxter Sales Value Proportion by Product in 2024
Table 64. Baxter Sales Value Proportion by Application in 2024
Table 65. Baxter Sales Value Proportion by Geographic Area in 2024
Table 66. Baxter Colloids (Blood Plasma) SWOT Analysis
Table 67. Baxter Recent Developments
Table 68. Grifols Corporation Information
Table 69. Grifols Description and Major Businesses
Table 70. Grifols Product Models, Descriptions and Specifications
Table 71. Grifols Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 72. Grifols Sales Value Proportion by Product in 2024
Table 73. Grifols Sales Value Proportion by Application in 2024
Table 74. Grifols Sales Value Proportion by Geographic Area in 2024
Table 75. Grifols Colloids (Blood Plasma) SWOT Analysis
Table 76. Grifols Recent Developments
Table 77. Octapharma Corporation Information
Table 78. Octapharma Description and Major Businesses
Table 79. Octapharma Product Models, Descriptions and Specifications
Table 80. Octapharma Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 81. Octapharma Sales Value Proportion by Product in 2024
Table 82. Octapharma Sales Value Proportion by Application in 2024
Table 83. Octapharma Sales Value Proportion by Geographic Area in 2024
Table 84. Octapharma Colloids (Blood Plasma) SWOT Analysis
Table 85. Octapharma Recent Developments
Table 86. Kedrion Corporation Information
Table 87. Kedrion Description and Major Businesses
Table 88. Kedrion Product Models, Descriptions and Specifications
Table 89. Kedrion Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 90. Kedrion Sales Value Proportion by Product in 2024
Table 91. Kedrion Sales Value Proportion by Application in 2024
Table 92. Kedrion Sales Value Proportion by Geographic Area in 2024
Table 93. Kedrion Colloids (Blood Plasma) SWOT Analysis
Table 94. Kedrion Recent Developments
Table 95. Shanghai Raas Corporation Information
Table 96. Shanghai Raas Description and Major Businesses
Table 97. Shanghai Raas Product Models, Descriptions and Specifications
Table 98. Shanghai Raas Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 99. Shanghai Raas Recent Developments
Table 100. CTBB Corporation Information
Table 101. CTBB Description and Major Businesses
Table 102. CTBB Product Models, Descriptions and Specifications
Table 103. CTBB Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 104. CTBB Recent Developments
Table 105. Hualan Bio Corporation Information
Table 106. Hualan Bio Description and Major Businesses
Table 107. Hualan Bio Product Models, Descriptions and Specifications
Table 108. Hualan Bio Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 109. Hualan Bio Recent Developments
Table 110. Rongsheng Pharmaceutical Corporation Information
Table 111. Rongsheng Pharmaceutical Description and Major Businesses
Table 112. Rongsheng Pharmaceutical Product Models, Descriptions and Specifications
Table 113. Rongsheng Pharmaceutical Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 114. Rongsheng Pharmaceutical Recent Developments
Table 115. Boya Rongsheng Corporation Information
Table 116. Boya Rongsheng Description and Major Businesses
Table 117. Boya Rongsheng Product Models, Descriptions and Specifications
Table 118. Boya Rongsheng Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 119. Boya Rongsheng Recent Developments
Table 120. B. Braun Medical Corporation Information
Table 121. B. Braun Medical Description and Major Businesses
Table 122. B. Braun Medical Product Models, Descriptions and Specifications
Table 123. B. Braun Medical Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 124. B. Braun Medical Recent Developments
Table 125. Fresenius Kabi Corporation Information
Table 126. Fresenius Kabi Description and Major Businesses
Table 127. Fresenius Kabi Product Models, Descriptions and Specifications
Table 128. Fresenius Kabi Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 129. Fresenius Kabi Recent Developments
Table 130. HOSPIRA Corporation Information
Table 131. HOSPIRA Description and Major Businesses
Table 132. HOSPIRA Product Models, Descriptions and Specifications
Table 133. HOSPIRA Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 134. HOSPIRA Recent Developments
Table 135. Axa parenterals Corporation Information
Table 136. Axa parenterals Description and Major Businesses
Table 137. Axa parenterals Product Models, Descriptions and Specifications
Table 138. Axa parenterals Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 139. Axa parenterals Recent Developments
Table 140. Fresenius Kabi (China) Corporation Information
Table 141. Fresenius Kabi (China) Description and Major Businesses
Table 142. Fresenius Kabi (China) Product Models, Descriptions and Specifications
Table 143. Fresenius Kabi (China) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 144. Fresenius Kabi (China) Recent Developments
Table 145. CR Double-Crane Corporation Information
Table 146. CR Double-Crane Description and Major Businesses
Table 147. CR Double-Crane Product Models, Descriptions and Specifications
Table 148. CR Double-Crane Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 149. CR Double-Crane Recent Developments
Table 150. Kelun Group Corporation Information
Table 151. Kelun Group Description and Major Businesses
Table 152. Kelun Group Product Models, Descriptions and Specifications
Table 153. Kelun Group Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 154. Kelun Group Recent Developments
Table 155. Shandong Qidu Pharmaceutical Corporation Information
Table 156. Shandong Qidu Pharmaceutical Description and Major Businesses
Table 157. Shandong Qidu Pharmaceutical Product Models, Descriptions and Specifications
Table 158. Shandong Qidu Pharmaceutical Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 159. Shandong Qidu Pharmaceutical Recent Developments
Table 160. Shandong Hualu Pharmaceutical Corporation Information
Table 161. Shandong Hualu Pharmaceutical Description and Major Businesses
Table 162. Shandong Hualu Pharmaceutical Product Models, Descriptions and Specifications
Table 163. Shandong Hualu Pharmaceutical Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 164. Shandong Hualu Pharmaceutical Recent Developments
Table 165. Minsheng Pharma Corporation Information
Table 166. Minsheng Pharma Description and Major Businesses
Table 167. Minsheng Pharma Product Models, Descriptions and Specifications
Table 168. Minsheng Pharma Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 169. Minsheng Pharma Recent Developments
Table 170. Kanglepharm Corporation Information
Table 171. Kanglepharm Description and Major Businesses
Table 172. Kanglepharm Product Models, Descriptions and Specifications
Table 173. Kanglepharm Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 174. Kanglepharm Recent Developments
Table 175. Key Raw Materials Distribution
Table 176. Raw Materials Key Suppliers
Table 177. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 178. Milestones in Production Technology Evolution
Table 179. Distributors List
Table 180. Market Trends and Market Evolution
Table 181. Market Drivers and Opportunities
Table 182. Market Challenges, Risks, and Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Colloids (Blood Plasma) Product Picture
Figure 2. Global Colloids (Blood Plasma) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Natural Type Colloids (Blood Plasma) Product Picture
Figure 4. Synthetic Type Colloids (Blood Plasma) Product Picture
Figure 5. Global Colloids (Blood Plasma) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Extensive Burns
Figure 7. Massive Blood or Plasma Loss
Figure 8. Hypovolemic Shock
Figure 9. Others
Figure 10. Colloids (Blood Plasma) Report Years Considered
Figure 11. Global Colloids (Blood Plasma) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Colloids (Blood Plasma) Revenue (2020-2031) & (US$ Million)
Figure 13. Global Colloids (Blood Plasma) Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Colloids (Blood Plasma) Revenue Market Share by Region (2020-2031)
Figure 15. Global Colloids (Blood Plasma) Sales (2020-2031) & (MT)
Figure 16. Global Colloids (Blood Plasma) Sales (CAGR) by Region (2020-2031) (MT)
Figure 17. Global Colloids (Blood Plasma) Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Colloids (Blood Plasma) Sales Volume Market Share in 2024
Figure 19. Global Colloids (Blood Plasma) Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Natural Type Colloids (Blood Plasma) Revenue Market Share by Manufacturer in 2024
Figure 22. Synthetic Type Colloids (Blood Plasma) Revenue Market Share by Manufacturer in 2024
Figure 23. Global Colloids (Blood Plasma) Sales Market Share by Type (2020-2031)
Figure 24. Global Colloids (Blood Plasma) Revenue Market Share by Type (2020-2031)
Figure 25. Global Colloids (Blood Plasma) Sales Market Share by Application (2020-2031)
Figure 26. Global Colloids (Blood Plasma) Revenue Market Share by Application (2020-2031)
Figure 27. North America Colloids (Blood Plasma) Sales YoY (2020-2031) & (MT)
Figure 28. North America Colloids (Blood Plasma) Revenue YoY (2020-2031) & (US$ Million)
Figure 29. North America Top 5 Manufacturers Colloids (Blood Plasma) Sales Revenue (US$ Million) in 2024
Figure 30. North America Colloids (Blood Plasma) Sales Volume (MT) by Type (2020- 2031)
Figure 31. North America Colloids (Blood Plasma) Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 32. North America Colloids (Blood Plasma) Sales Volume (MT) by Application (2020-2031)
Figure 33. North America Colloids (Blood Plasma) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 34. US Colloids (Blood Plasma) Revenue (2020-2031) & (US$ Million)
Figure 35. Canada Colloids (Blood Plasma) Revenue (2020-2031) & (US$ Million)
Figure 36. Mexico Colloids (Blood Plasma) Revenue (2020-2031) & (US$ Million)
Figure 37. Europe Colloids (Blood Plasma) Sales YoY (2020-2031) & (MT)
Figure 38. Europe Colloids (Blood Plasma) Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Europe Top 5 Manufacturers Colloids (Blood Plasma) Sales Revenue (US$ Million) in 2024
Figure 40. Europe Colloids (Blood Plasma) Sales Volume (MT) by Type (2020-2031)
Figure 41. Europe Colloids (Blood Plasma) Sales Revenue (US$ Million) by Type (2020-2031)
Figure 42. Europe Colloids (Blood Plasma) Sales Volume (MT) by Application (2020-2031)
Figure 43. Europe Colloids (Blood Plasma) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 44. Germany Colloids (Blood Plasma) Revenue (2020-2031) & (US$ Million)
Figure 45. France Colloids (Blood Plasma) Revenue (2020-2031) & (US$ Million)
Figure 46. U.K. Colloids (Blood Plasma) Revenue (2020-2031) & (US$ Million)
Figure 47. Italy Colloids (Blood Plasma) Revenue (2020-2031) & (US$ Million)
Figure 48. Russia Colloids (Blood Plasma) Revenue (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Colloids (Blood Plasma) Sales YoY (2020-2031) & (MT)
Figure 50. Asia-Pacific Colloids (Blood Plasma) Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Asia-Pacific Top 8 Manufacturers Colloids (Blood Plasma) Sales Revenue (US$ Million) in 2024
Figure 52. Asia-Pacific Colloids (Blood Plasma) Sales Volume (MT) by Type (2020- 2031)
Figure 53. Asia-Pacific Colloids (Blood Plasma) Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 54. Asia-Pacific Colloids (Blood Plasma) Sales Volume (MT) by Application (2020-2031)
Figure 55. Asia-Pacific Colloids (Blood Plasma) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 56. Indonesia Colloids (Blood Plasma) Revenue (2020-2031) & (US$ Million)
Figure 57. Japan Colloids (Blood Plasma) Revenue (2020-2031) & (US$ Million)
Figure 58. South Korea Colloids (Blood Plasma) Revenue (2020-2031) & (US$ Million)
Figure 59. China Taiwan Colloids (Blood Plasma) Revenue (2020-2031) & (US$ Million)
Figure 60. India Colloids (Blood Plasma) Revenue (2020-2031) & (US$ Million)
Figure 61. Central and South America Colloids (Blood Plasma) Sales YoY (2020-2031) & (MT)
Figure 62. Central and South America Colloids (Blood Plasma) Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Central and South America Top 5 Manufacturers Colloids (Blood Plasma) Sales Revenue (US$ Million) in 2024
Figure 64. Central and South America Colloids (Blood Plasma) Sales Volume (MT) by Type (2021-2031)
Figure 65. Central and South America Colloids (Blood Plasma) Sales Revenue (US$ Million) by Type (2020-2031)
Figure 66. Central and South America Colloids (Blood Plasma) Sales Volume (MT) by Application (2020-2031)
Figure 67. Central and South America Colloids (Blood Plasma) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 68. Brazil Colloids (Blood Plasma) Revenue (2020-2025) & (US$ Million)
Figure 69. Argentina Colloids (Blood Plasma) Revenue (2020-2025) & (US$ Million)
Figure 70. Middle East, and Africa Colloids (Blood Plasma) Sales YoY (2020-2031) & (MT)
Figure 71. Middle East and Africa Colloids (Blood Plasma) Revenue YoY (2020-2031) & (US$ Million)
Figure 72. Middle East and Africa Top 5 Manufacturers Colloids (Blood Plasma) Sales Revenue (US$ Million) in 2024
Figure 73. Middle East and Africa Colloids (Blood Plasma) Sales Volume (MT) by Type (2021-2031)
Figure 74. South America Colloids (Blood Plasma) Sales Revenue (US$ Million) by Type (2020-2031)
Figure 75. Middle East and Africa Colloids (Blood Plasma) Sales Volume (MT) by Application (2020-2031)
Figure 76. Middle East and Africa Colloids (Blood Plasma) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 77. GCC Countries Colloids (Blood Plasma) Revenue (2020-2025) & (US$ Million)
Figure 78. Turkey Colloids (Blood Plasma) Revenue (2020-2025) & (US$ Million)
Figure 79. Egypt Colloids (Blood Plasma) Revenue (2020-2025) & (US$ Million)
Figure 80. South Africa Colloids (Blood Plasma) Revenue (2020-2025) & (US$ Million)
Figure 81. Colloids (Blood Plasma) Industry Chain Mapping
Figure 82. Regional Colloids (Blood Plasma) Manufacturing Base Distribution (%)
Figure 83. Global Colloids (Blood Plasma) Production Market Share by Region (2020-2031)
Figure 84. Colloids (Blood Plasma) Production Process
Figure 85. Regional Colloids (Blood Plasma) Production Cost Structure
Figure 86. Channels of Distribution (Direct Vs Distribution)
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Colloids (Blood Plasma) in 2031?
The global market size of Colloids (Blood Plasma) in 2031 was 325 Million USD.
What was the global market size of Colloids (Blood Plasma) in 2025?
What is the annual compound growth rate of the global Colloids (Blood Plasma) market size from 2025 to 2031?
Which region is expected to have the highest market share?
Which companies rank high in the global Colloids (Blood Plasma) market?
Related Reports
Global Colloids (Blood Plasma) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Colloids (Blood Plasma) market size was US$ 378 million in 2025 and is forecast to reach a readjusted size of US$ 317 million by 2032 with a CAGR of -2.5% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 114
USD 4250.00
(Single User License)
Global Colloids (Blood Plasma) Market Research Report 2026
The global Colloids (Blood Plasma) market was valued at US$ 378 million in 2025 and is anticipated to reach US$ 317 million by 2032, at a CAGR of -2.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 143
USD 2900.00
(Single User License)
Colloids (Blood Plasma)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Colloids (Blood Plasma) was estimated to be worth US$ 378 million in 2025 and is projected to reach US$ 317 million, growing at a CAGR of -2.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 167
USD 3950.00
(Single User License)
Global Colloids (Blood Plasma) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Colloids (Blood Plasma) was estimated to be worth US$ 387 million and is forecast to reach approximately US$ 325 million by 2031 with a CAGR of -2.5% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 196
USD 5900.00
(Single User License)
Global Colloids (Blood Plasma) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Colloids (Blood Plasma) market size was US$ 387 million in 2024 and is forecast to a readjusted size of US$ 325 million by 2031 with a CAGR of -2.5% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 119
USD 4250.00
(Single User License)
Colloids (Blood Plasma)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Colloids (Blood Plasma) was estimated to be worth US$ 387 million in 2024 and is forecast to a readjusted size of US$ 325 million by 2031 with a CAGR of -2.5% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 157
USD 3950.00
(Single User License)
Global Colloids (Blood Plasma) Market Research Report 2025
The global market for Colloids (Blood Plasma) was valued at US$ 387 million in the year 2024 and is projected to reach a revised size of US$ 325 million by 2031, growing at a CAGR of -2.5% during the forecast period.
Published Date: 2025-01-16
Pages: 115
USD 2900.00
(Single User License)
Global Colloids (Blood Plasma) Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Published Date: 2024-04-17
Pages: 202
USD 5600.00
(Single User License)
Global Colloids (Blood Plasma) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Published Date: 2024-04-16
Pages: 192
USD 5900.00
(Single User License)
Global Colloids (Blood Plasma) Market Insights, Forecast to 2030
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Published Date: 2024-04-07
Pages: 125
USD 4900.00
(Single User License)
Global Colloids (Blood Plasma) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Colloids (Blood Plasma) market size was US$ 378 million in 2025 and is forecast to reach a readjusted size of US$ 317 million by 2032 with a CAGR of -2.5% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 114
USD 4250.00 (Single User License)Global Colloids (Blood Plasma) Market Research Report 2026
The global Colloids (Blood Plasma) market was valued at US$ 378 million in 2025 and is anticipated to reach US$ 317 million by 2032, at a CAGR of -2.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 143
USD 2900.00 (Single User License)Colloids (Blood Plasma)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Colloids (Blood Plasma) was estimated to be worth US$ 378 million in 2025 and is projected to reach US$ 317 million, growing at a CAGR of -2.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 167
USD 3950.00 (Single User License)Global Colloids (Blood Plasma) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Colloids (Blood Plasma) was estimated to be worth US$ 387 million and is forecast to reach approximately US$ 325 million by 2031 with a CAGR of -2.5% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 196
USD 5900.00 (Single User License)Global Colloids (Blood Plasma) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Colloids (Blood Plasma) market size was US$ 387 million in 2024 and is forecast to a readjusted size of US$ 325 million by 2031 with a CAGR of -2.5% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 119
USD 4250.00 (Single User License)Colloids (Blood Plasma)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Colloids (Blood Plasma) was estimated to be worth US$ 387 million in 2024 and is forecast to a readjusted size of US$ 325 million by 2031 with a CAGR of -2.5% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 157
USD 3950.00 (Single User License)Global Colloids (Blood Plasma) Market Research Report 2025
The global market for Colloids (Blood Plasma) was valued at US$ 387 million in the year 2024 and is projected to reach a revised size of US$ 325 million by 2031, growing at a CAGR of -2.5% during the forecast period.
Published: 2025-01-16
Pages: 115
USD 2900.00 (Single User License)Global Colloids (Blood Plasma) Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Published: 2024-04-17
Pages: 202
USD 5600.00 (Single User License)Global Colloids (Blood Plasma) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Published: 2024-04-16
Pages: 192
USD 5900.00 (Single User License)Global Colloids (Blood Plasma) Market Insights, Forecast to 2030
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Published: 2024-04-07
Pages: 125
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now